Management
Management
| Name | Title | Employed since | Number of shares |
| Ernst Westman | Managing Director for Boule Diagnostics AB | 1994 | 177 392* |
| Annika Karlén | Head of Marketing, Europe, Africa and Asia | 2009 | 0 |
| Karen Bornstein | Head of Marketing, North and South America | 2004 | 0 |
| Fredrik Alpsten | Chief Financial Officer | 2011 | 0 |
| Claes Blanche | President and CEO of Boule Medical AB | 2012 | 0 |
| Hans Johansson | Head of Production Boule Medical AB and Managing Director for Boule Medical (Beijing) Co Ltd | 2001 | 8 434 |
| Andrew Swanson | President and Chief Executive Officer for CDS, inc., board member | 2004 | 169 538 |
| Mike Eliott | Head of Development for Reagents and Consumables | 1992 | 15 258 |
| Thomas Olsson | Head of Quality Control and Regulatory Affairs | 1992 | 86 312 |
*both private and comapny
 |
Ernst Westman has held the position of Managing Director for Boule Diagnostics since 1996 and has been employed since 1994. Completed board work during the past five years: Sinoreagens AB. Education: Ernst Westman has a civil engineers degree specialising in chemistry from Chalmers University of Technology in Gothenburg. Shareholding in Boule: 177,392 shares (private and through the company). |
Annika Karlén is the Head of Marketing responsible for sales and marketing in Europe, Asia, Africa and the Middle East and for OEM sales of systems. She has been employed by Boule since 2009. Completed board assignments during the past five years: MD, Orion Diagnostica AB.
Education: Annika Karlén is a licensed biomedical analyst with a degree from the School of Health Sciences in Jönköping.
Shareholding in Boule: 0
Karen Bornstein is the Head of Marketing responsible for sales and marketing in North and South America as well as OEM sales of consumables. She has been employed by Boule since 2009. Education: Karen Bornstein has Bachelor of Science, Medical Technology and Advanced studies MD Anderson Cancer Institute, University of Texas.
Shareholding in Boule: 0
Fredrik Alpsten is Chief Financial Officer and has been employed by Boule since 2011.
Board assignments: Chairman Personlig Almanacka Nordic AB
Completed board work and other assignments during the last five years: President CEO Doxa AB and before that Chief Financial Officer at Doxa AB
Education: Master of Science, Business administration from Stockholm School of Economics
Shareholding in Boule: 0 shares.
Claes Blanche is the CEO of Boule Medical AB and employed since January 2012.
Board assignments: Member of Toul Meditech AB.
Completed board work and other assignments during the last five years: CEO of Sorin Scandinavia AB, CEO of Guidant AB, member of the board of Nordic BioLab AB.
Education: Claes is a civil engineer from Biochemistry KTH, Stockholm.
Sharholding in Boule: 0 shares.
Hans Johansson is Head of Production at Boule Medical and is Managing Director for Boule Medical (Beijing) and employed by Boule since 2001.Education: Hans Johansson has a graduate degree in engineering physics from Linköpings Institute of Technology.
Shareholding in Boule: 8,434 shares.
Andrew Swanson is the President and CEO for DCS and has been employed by Boule since 2004. He is a member of the board of Boule Diagnostics AB. Education: Bachelors degree in electronics and business economics from the University of Illinois.
Shareholding in Boule: 169,538 shares.
Mike Eliott is Head of Development for Reagents at CDS and has been employed by Boule since 2004. Education: Mike Eliott has a Masters degree in biochemistry and marine biology from Queens University of Belfast and an MBA from Florida Atlantic University.
Shareholding in Boule: 15,258 shares.
Thomas Olsson is responsible for quality control and has been employed by Boule since 1992.Education: Thomas Olsson has a PhD in biochemistry from Stockholm University.
Shareholding in Boule: 86,312 shares.
